again

Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer

In a finding that broadens our insight intothe cause of certain kinds of UV-induced skin cancer, researchers atErasmus University Medical Center (Rotterdam, The Netherlands) haveemployed an evolutionarily ancient enzyme-repair system to identify theprincipal type of DNA damage responsible for the onset of skin-tumordevelopment. The researchers' findings also suggest that this enzymesystem m...

Bound for destruction: Ubiquitination protects against improper Notch signaling

The is an important molecular signaling mechanism whose existence has beenknown, or at least hinted at, for nearly a century since theidentification of a mutant strain of Drosophila fruit flies with“notched?wings in Thomas Hunt Morgan’s lab in 1910. Later studiesrevealed that the Notch gene encodes a receptor protein tha...

Female sex hormones play a vital role in defense against sexually transmitted diseases

Two McMaster University studies, to be published in the Journal of Virology, show that sex hormones have a profound effect on susceptibility of female mice to the herpes simplex virus, type 2 (HSV-2 ), one of the most common sexually transmitted diseases. Charu Kaushic, assistant professor and supervisor of the studies, says the implication of this work is quite significant. "The research...

In the sea slug's defense against lobsters, confusion is key

Like many other marine creatures, Aplysia, a common sea slug, enlists chemical defenses against its predators, but the mechanisms by which such chemical attacks actually work against their intended targets are not well understood by researchers. New work has now shown that such chemical defenses can involve modes of trickery that had not previously been appreciated as components of chemical defen...

First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers

Two compounds that zero in on cancer cells spreading throughout the body, while ignoring primary tumor cells, could someday give doctors a whole new weapon in the fight against tough-to-treat metastatic disease, according to Weill Medical College of Cornell University researchers. The compounds, called synthetic migrastatin analogues, prevented 91 to 99 percent of metastatic breast cancer...

More>>

again at Biology Products

Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Description:Defender against cell death 1...
Company:GenWay Biotech, Inc.

again at Biology Technology

Rodney Dykehouse of Froedtert and Medical College of Wisconsin warns against tech for its own sake

For the CIO, implementing electronic medical r...

Protector RNase Inhibitor Enhance the Protection of RNA against Degradation

Is a new type of RNase inhibitor and inhibits a wide known spectrum ofRNases. Does not interfere with the performance of enzymes in an assay - evenwhen high amounts (e.g., up to 16-fold the standard concentr...

Protecting your business against online brand abuse

The Internet does connect you with your customers - and your customers with potentially fraudulent or disparaging websites and e-mails that could damage your reputation and sales. Here are several potential brand threats to small businesses online, r...

Madison again ranks as most digitized city

In its The Center for Digit...

NovaScan decides against tax credits

The company instead has raised a total of $385,000 from a combination of fiv...

More>>

again at Medicine News

Multi billion-dollar suit filed against cell phone firm for causing brain tumours

In the United States of America, a lawyer- Peter Angelos, who won millions of dollars as compensation from the tobacco industry in Maryland, has announced that he is dragging Vodafone to court in a billion dollar suit. He is claiming compensation to cell phone users who are said to have developed brain tumours after using the instruments made by Verizon wireless. This case has raised eyeb...

Man against HIV – new vaccine ready for human trials

A new vaccine called the TAT vaccine has been developed in Italy as the latest and most exciting HIV vaccine to date. And more importantly it has had a 71% success rate when tested on monkeys. This vaccine is now ready for human testing and this may be the brightest hope for mankind against the destructive HIV. Dr.Barbara Ensoli, Head of the Department of Virology at Italy’s National Hea...

Antibiotics losing their power against acne

Acne has always been a major problem with teenagers. Pimples have been described by teens as an embarrassing and nagging problem. With beauty business becoming a multi billion-dollar industry, every one wants a blemish less skin and a spotless complexion. Every year a new Indian girl wins an international beauty pageant and the focus now is on looking your best. Pimples (acne) spoil...

South Africa Wins landmark case against pharmaceutical giants

South Africa has scored a landmark legal victory over pharmaceutical giants wanting to stop South Africa from importing cheap AIDS drugs. The country with largest number of AIDS patients in the world now wants to secure affordable drugs from around the world to tackle its AIDS epidemic. The Health Ministry of South Africa, published 70 pages of draft legislation that would allow it to s...

Vitamin E, the latest warrior against diabetes

Scientists are assessing research that suggests high doses of vitamin E may help fight diabetes. Diabetes is one of the most prevalent diseases in the world with many ravaging complications, affecting millions of people. Complications can lead to heart disease, eye damage, kidney failure, non healing ulcers all over the body and can also cause complications of the nervous system. Diabet...

More>>

again at Medicine Products

No data found

Search again medicine products at Google

Search again medicine products at Yahoo

Search again medicine products at Msn

again at Medicine Technology

RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments

IRVING, Texas--(BUSINESS WIRE)--Jun 29, 2007 - ReataPharmaceuticals, Inc. today announced the presentation of newpreclinical data showing their lead anti-cancer agent, theSynthetic Triterpenoid RTA 402, is effective at protecting againstcommon toxicities caused by traditional cancer treatments. Thisdata was presented at the annual meeting of the MultinationalAssociation of Supportive Care i...

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types

Results also show significant additional protection againstinfection with virus types beyond 16 and 18 with the GSK cervicalcancer candidate vaccine PHILADELPHIA, June 27, 2007 /PRNewswire-FirstCall/ -- Resultsfrom an interim analysis of a Phase III study show thatCERVARIX(R), the GlaxoSmithKline cervical cancer candidate vaccine,provides up to 100 percent protection against advanced prec...

In Vitro and In Vivo Data Show Alfacell's Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells

Pre-Clinical Results Demonstrate Potential of ONCONASE forTreatment of Neuroblastoma BLOOMFIELD, N.J., June 27, 2007 /PRNewswire-FirstCall/ --Alfacell Corporation today announced that new data show ONCONASE,the company's lead drug candidate, is active against naive andchemoresistant neuroblastoma cells. The pre-clinical in vitro and in vivo data published in CancerLetters (2007; Vo...

New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus

HIGH WYCOMBE, UK 18th June 2007-Previously undisclosedpre-clinical data showing how a new flu vaccine has the potentialto protect against all strains of influenza, including pandemic andannual, was presented today by PepTcell, at the 2007 Options forthe Control of Influenza VI (Options) Conference, in Toronto,Canada. The pre-cli...

New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus

Data Presented at Leading Influenza Conference HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ -- Previouslyundisclosed pre-clinical data showing how a new flu vaccine has thepotential to protect against all strains of influenza, includingpandemic and annual, was presented today by PepTcell, at the 2007Options for the Control of Influenza VI (Options) Conference, inToronto, Canada....

More>>